Search Results 4131-4140 of 36494 for oral
This is an Open Label, Multicenter, pilot clinical trial to assess the efficacy and safety of an oral selective Endothelin Receptor Antagonist (ambrisentan) in ...
Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...
Receiving systemic immunosuppressive therapy (> 2 weeks) including oral steroid doses > 10 mg/day of prednisone or equivalent within 2 months prior to ...
... Oral biopsy, Microvascular surgery, Facial reconstruction, Skull base surgery, Glossectomy, Tracheostomy, Skin cancer reconstruction, Submandibular gland ...
Oral or vaginal candidiasis and cutaneous or nail fungal infections do not constitute an exclusion. Any of the following within 12 weeks prior to Day 1 ...
TP-0903 is a novel oral inhibitor that targets AXL kinase and reverses the mesenchymal phenotype associated with advanced cancers. TP-0903 has demonstrated ...
... oral anticoagulant; or has a documented coagulopathy; Atrial fibrillation with resting HR > 100 BPM; Resting arterial oxygen saturation < 95% on room air ...
... oral presentation awarded the YIA Top Rated Abstract oral presentation at iwCLL 2019. Medical school: University of Missouri, Columbia School of Medicine ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!